Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2013-04-10 Regulatory Filings
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
102年3月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 景岳, with data for March of the 102nd year of the Republic of China calendar (which corresponds to 2013). It includes percentage changes compared to the previous year and notes on accounting standards (IFRS) implementation. The document is very short (763 characters) and primarily presents financial summary data without detailed financial statements or management discussion. It does not appear to be a full annual or interim report, nor an earnings release or investor presentation. It is more of a regulatory or public disclosure of financial summary data. Given the short length and nature, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2013-04-10 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (景岳生物科技股份有限公司) regarding its commitments and subsequent execution related to its application for stock listing transfer from over-the-counter to the main board. It details compliance with regulatory requirements from the Taiwan Stock Exchange, including financial reporting commitments and board resolutions. The document is short (1117 characters) and primarily serves as a regulatory disclosure of compliance status and corporate governance actions rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-04-01 Chinese
101年第4季海外子公司投資
Interim / Quarterly Report Classification · 95% confidence The document is a brief financial disclosure related to overseas subsidiary investment details for a specific quarter (101 year 4th quarter, which corresponds to a fiscal period). It contains tabulated data on investment amounts, shareholding percentages, and investment gains/losses. The length is very short (502 characters), and it provides specific financial data for a quarter, not just an announcement or a link to a report. This matches the characteristics of an Interim / Quarterly Report (IR) as it contains substantive financial data for a period shorter than a full fiscal year. It is not an announcement or a certification, nor is it a full annual report or earnings release. Therefore, the best classification is IR. FY 2012
2013-03-29 Chinese
101年第4季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment information related to the company's investments in mainland China, including capital amounts, investment methods, and recognized investment gains or losses. It includes notes explaining the investment methods and accounting bases for investment gains. The document is relatively short (1345 characters) and does not contain comprehensive financial statements or management discussion. It appears to be a regulatory disclosure of investment details rather than a full financial report or announcement of a report. This type of detailed investment disclosure fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-03-29 Chinese
公告今日(3/27)地震對本公司之財務及業務並無重大影響
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company (景岳生物科技股份有限公司) stating that a recent earthquake had no significant impact on its financials or business. It is dated 102/03/27 (Taiwan calendar year, corresponding to 2013). The content is a factual disclosure about an event affecting the company, without any financial data, detailed report, or management discussion. It does not contain financial statements or detailed analysis, nor does it announce a report publication. It is a regulatory announcement about a material event affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-03-27 Chinese
董事會決議股利分派
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (727 characters) from a company (3164 景岳) disclosing the board resolution on dividend distribution, including cash dividend per share, total cash dividend amount, and other related details. It is not a full report but a specific announcement about dividend decisions made by the board. There is no detailed financial statement or comprehensive report content. The document fits the definition of a Notice of Dividend Amount (DIV) as it announces dividend amounts and payment details to shareholders.
2013-03-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.